Trial intelligence / Profile preview

Physostigmine for treatment of perioperative ICU delirium

2012-004082-41Phase 3Terminated

Sponsor
Goethe University Frankfurt
Start
Jan 2013
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of physostigmine in delirium, sponsored by Goethe University Frankfurt. Started Jan 2013; status: terminated.

02

Drugs

physostigmine
03

Conditions

delirium

Beyond the preview

Go deeper on 2012-004082-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004082-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call